Altruism, personal benefit, and anxieties: a phenomenological study of healthy volunteers' experiences in a placebo-controlled trial of duloxetine.

Saved in:
Bibliographic Details
Title: Altruism, personal benefit, and anxieties: a phenomenological study of healthy volunteers' experiences in a placebo-controlled trial of duloxetine.
Authors: Kwakye, Isaac N., Garner, Matthew, Baldwin, David S., Bamford, Susan, Pinkney, Verity, Bishop, Felicity L.
Source: Human Psychopharmacology: Clinical & Experimental. Jul2016, Vol. 31 Issue 4, p332-340. 9p.
Subjects: Duloxetine, Psychiatric drugs, Mental depression, Therapeutics, Generalized anxiety disorder, Placebos
Abstract: Objective The objective of this study was to develop an in-depth understanding of healthy volunteers' experiences of mental health trials. Methods A qualitative study was nested within a healthy volunteer placebo-controlled trial of duloxetine, a psychotropic drug used for treating patients with major depression and generalized anxiety disorder. Eight participants were interviewed, and data were analyzed using interpretative phenomenological analysis. Results Interviewees described volunteering for the trial because they were interested in research, wanted the monetary incentive, wanted to help researchers, and wanted to be part of something. On entering the trial, participants considered the possible risks and described feeling anxious, excited, and determined; they had some clear expectations and some loosely held hopes about what would happen. During the trial, participants were curious about whether they were taking duloxetine or placebo, self-monitored their bodies' reactions, and guessed which treatment they received. On being un-blinded to treatment allocation after completing the trial, some participants' guesses were confirmed, but others were surprised, and a few were disappointed. Conclusions Small changes to advertising/consent materials to reflect volunteers' motivations could improve recruitment rates to similar trials; 'active' placebos might be particularly useful for maintaining blinding in healthy volunteer trials; and sensitive procedures are needed for un-blinding participants to treatment allocation. Copyright © 2016 John Wiley & Sons, Ltd. [ABSTRACT FROM AUTHOR]
Copyright of Human Psychopharmacology: Clinical & Experimental is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database: Psychology and Behavioral Sciences Collection
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: pbh
DbLabel: Psychology and Behavioral Sciences Collection
An: 116620141
AccessLevel: 6
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Altruism, personal benefit, and anxieties: a phenomenological study of healthy volunteers' experiences in a placebo-controlled trial of duloxetine.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Kwakye%2C+Isaac+N%2E%22">Kwakye, Isaac N.</searchLink><br /><searchLink fieldCode="AR" term="%22Garner%2C+Matthew%22">Garner, Matthew</searchLink><br /><searchLink fieldCode="AR" term="%22Baldwin%2C+David+S%2E%22">Baldwin, David S.</searchLink><br /><searchLink fieldCode="AR" term="%22Bamford%2C+Susan%22">Bamford, Susan</searchLink><br /><searchLink fieldCode="AR" term="%22Pinkney%2C+Verity%22">Pinkney, Verity</searchLink><br /><searchLink fieldCode="AR" term="%22Bishop%2C+Felicity+L%2E%22">Bishop, Felicity L.</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Human+Psychopharmacology%3A+Clinical+%26+Experimental%22">Human Psychopharmacology: Clinical & Experimental</searchLink>. Jul2016, Vol. 31 Issue 4, p332-340. 9p.
– Name: Subject
  Label: Subjects
  Group: Su
  Data: <searchLink fieldCode="DE" term="%22Duloxetine%22">Duloxetine</searchLink><br /><searchLink fieldCode="DE" term="%22Psychiatric+drugs%22">Psychiatric drugs</searchLink><br /><searchLink fieldCode="DE" term="%22Mental+depression%22">Mental depression</searchLink><br /><searchLink fieldCode="DE" term="%22Therapeutics%22">Therapeutics</searchLink><br /><searchLink fieldCode="DE" term="%22Generalized+anxiety+disorder%22">Generalized anxiety disorder</searchLink><br /><searchLink fieldCode="DE" term="%22Placebos%22">Placebos</searchLink>
– Name: Abstract
  Label: Abstract
  Group: Ab
  Data: Objective The objective of this study was to develop an in-depth understanding of healthy volunteers' experiences of mental health trials. Methods A qualitative study was nested within a healthy volunteer placebo-controlled trial of duloxetine, a psychotropic drug used for treating patients with major depression and generalized anxiety disorder. Eight participants were interviewed, and data were analyzed using interpretative phenomenological analysis. Results Interviewees described volunteering for the trial because they were interested in research, wanted the monetary incentive, wanted to help researchers, and wanted to be part of something. On entering the trial, participants considered the possible risks and described feeling anxious, excited, and determined; they had some clear expectations and some loosely held hopes about what would happen. During the trial, participants were curious about whether they were taking duloxetine or placebo, self-monitored their bodies' reactions, and guessed which treatment they received. On being un-blinded to treatment allocation after completing the trial, some participants' guesses were confirmed, but others were surprised, and a few were disappointed. Conclusions Small changes to advertising/consent materials to reflect volunteers' motivations could improve recruitment rates to similar trials; 'active' placebos might be particularly useful for maintaining blinding in healthy volunteer trials; and sensitive procedures are needed for un-blinding participants to treatment allocation. Copyright © 2016 John Wiley & Sons, Ltd. [ABSTRACT FROM AUTHOR]
– Name: AbstractSuppliedCopyright
  Label:
  Group: Ab
  Data: <i>Copyright of Human Psychopharmacology: Clinical & Experimental is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract.</i> (Copyright applies to all Abstracts.)
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=pbh&AN=116620141
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1002/hup.2543
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 9
        StartPage: 332
    Subjects:
      – SubjectFull: Duloxetine
        Type: general
      – SubjectFull: Psychiatric drugs
        Type: general
      – SubjectFull: Mental depression
        Type: general
      – SubjectFull: Therapeutics
        Type: general
      – SubjectFull: Generalized anxiety disorder
        Type: general
      – SubjectFull: Placebos
        Type: general
    Titles:
      – TitleFull: Altruism, personal benefit, and anxieties: a phenomenological study of healthy volunteers' experiences in a placebo-controlled trial of duloxetine.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Kwakye, Isaac N.
      – PersonEntity:
          Name:
            NameFull: Garner, Matthew
      – PersonEntity:
          Name:
            NameFull: Baldwin, David S.
      – PersonEntity:
          Name:
            NameFull: Bamford, Susan
      – PersonEntity:
          Name:
            NameFull: Pinkney, Verity
      – PersonEntity:
          Name:
            NameFull: Bishop, Felicity L.
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 07
              Text: Jul2016
              Type: published
              Y: 2016
          Identifiers:
            – Type: issn-print
              Value: 08856222
          Numbering:
            – Type: volume
              Value: 31
            – Type: issue
              Value: 4
          Titles:
            – TitleFull: Human Psychopharmacology: Clinical & Experimental
              Type: main
ResultId 1